Emens LA - Search Results

1

A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism.

Manning EA, Ullman JG, Leatherman JM, Asquith JM, Hansen TR, Armstrong TD, Hicklin DJ, Jaffee EM, Emens LA. Manning EA, et al. Among authors: emens la. Clin Cancer Res. 2007 Jul 1;13(13):3951-9. doi: 10.1158/1078-0432.CCR-07-0374. Clin Cancer Res. 2007. PMID: 17606729

2

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.

Disis ML, Adams SF, Bajpai J, Butler MO, Curiel T, Dodt SA, Doherty L, Emens LA, Friedman CF, Gatti-Mays M, Geller MA, Jazaeri A, John VS, Kurnit KC, Liao JB, Mahdi H, Mills A, Zsiros E, Odunsi K. Disis ML, et al. Among authors: emens la. J Immunother Cancer. 2023 Jun;11(6):e006624. doi: 10.1136/jitc-2022-006624. J Immunother Cancer. 2023. PMID: 37295818 Free PMC article.

3

Immunotherapy Approaches for Breast Cancer Patients in 2023.

Emens LA, Loi S. Emens LA, et al. Cold Spring Harb Perspect Med. 2023 Apr 3;13(4):a041332. doi: 10.1101/cshperspect.a041332. Cold Spring Harb Perspect Med. 2023. PMID: 37011999 Review.

4

The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.

Reilly RT, Machiels JP, Emens LA, Ercolini AM, Okoye FI, Lei RY, Weintraub D, Jaffee EM. Reilly RT, et al. Among authors: emens la. Cancer Res. 2001 Feb 1;61(3):880-3. Cancer Res. 2001. PMID: 11221874

5

Chemotherapy: friend or foe to cancer vaccines?

Emens LA, Machiels JP, Reilly RT, Jaffee EM. Emens LA, et al. Curr Opin Mol Ther. 2001 Feb;3(1):77-84. Curr Opin Mol Ther. 2001. PMID: 11249735 Review.

6

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.

Machiels JP, Reilly RT, Emens LA, Ercolini AM, Lei RY, Weintraub D, Okoye FI, Jaffee EM. Machiels JP, et al. Among authors: emens la. Cancer Res. 2001 May 1;61(9):3689-97. Cancer Res. 2001. PMID: 11325840

7

Humoral and cellular immune responses: independent forces or collaborators in the fight against cancer?

Reilly RT, Emens LA, Jaffee EM. Reilly RT, et al. Among authors: emens la. Curr Opin Investig Drugs. 2001 Jan;2(1):133-5. Curr Opin Investig Drugs. 2001. PMID: 11527005 Review.

8

Cytokine gene-modified cell-based cancer vaccines.

Reilly RT, Machiels JP, Emens LA, Jaffee EM. Reilly RT, et al. Among authors: emens la. Methods Mol Med. 2002;69:233-57. doi: 10.1385/1-59259-141-8:233. Methods Mol Med. 2002. PMID: 11987781 Review. No abstract available.

9

To live or not to live: that depends on GAGE?

Emens LA, Jaffee EM. Emens LA, et al. Cancer Biol Ther. 2002 Jul-Aug;1(4):388-90. Cancer Biol Ther. 2002. PMID: 12432252 No abstract available.

10

Adjuvant hormonal therapy for premenopausal women with breast cancer.

Emens LA, Davidson NE. Emens LA, et al. Clin Cancer Res. 2003 Jan;9(1 Pt 2):486S-94S. Clin Cancer Res. 2003. PMID: 12538505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters